Physician

Ajay Kumar, MD

According to 2025 Medicare claims, Ajay Kumar, MD (NPI: 1962426817) practices endocrinology in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is MOSES CONE MEDICAL SERVICES, INC. (NPI: 1427095249; TIN: 561714318) and primary practice location at 27403-1127. Kumar is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Kumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 130 traditional Medicare patients, billed 1,701 HCPCS/CPT codes, and received $34,718 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,262 prescription claims across 466 beneficiaries totaling $2,225,150 in drug costs, led by Ozempic (Semaglutide). DME data shows 432 claims. Open Payments data shows 19 records totaling $353. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $96,313 to $34,718. In contrast, Part D prescription costs have risen steadily, from $1,489,743 to $2,225,150. For DME billing, reported payments moved sharply higher in recent years, from $14,922 to $116,575.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	293	3,520	$96,313
2016	307	3,521	$97,572
2017	291	3,379	$95,248
2018	284	3,554	$92,162
2019	264	3,478	$81,960
2020	232	3,265	$69,153
2021	198	2,760	$71,917
2022	160	2,097	$53,563
2023	180	3,046	$59,648
2024	130	1,701	$34,718

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	509	9,623	$1,489,743
2016	532	9,456	$1,939,035
2017	545	9,000	$2,080,348
2018	532	8,931	$2,556,264
2019	547	8,326	$2,752,604
2020	496	7,413	$2,700,735
2021	476	6,979	$2,730,495
2022	441	6,285	$2,682,811
2023	522	6,381	$3,131,271
2024	466	5,262	$2,225,150

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	242	724	$27,665
2016	216	680	$28,291
2017	170	581	$34,677
2018	151	561	$55,675
2019	140	471	$63,318
2020	122	503	$75,560
2021	96	497	$80,363
2022	110	584	$111,364
2023	121	613	$121,226
2024	94	432	$118,390

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	99	170	$80
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	51	92	$24
83036	Hemoglobin a1c level	93	172	$9
36415	Insertion of needle into vein for collection of blood sample	98	149	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	63	107	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	291	10,410	$344,865
Mounjaro	Tirzepatide	190	6,914	$249,507
Jardiance	Empagliflozin	284	11,983	$232,855
Farxiga	Dapagliflozin Propanediol	177	8,270	$149,320
Trulicity	Dulaglutide	92	3,136	$105,427

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	50	265	$90,572
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	37	$9,075
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	13	36	$7,992
E0784	External ambulatory infusion pump, insulin	Y	N/R	24	$7,581
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	13	33	$2,585

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$353	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajay Kumar, MD?

Tedicare shows public-source Medicare data for Ajay Kumar, MD (NPI 1962426817), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajay Kumar, MD have ACO affiliation data?

Ajay Kumar, MD is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Ajay Kumar, MD?

Ajay Kumar, MD is linked to MOSES CONE MEDICAL SERVICES, INC. (billing NPI 1427095249) in the available physician profile data.

Does Ajay Kumar, MD have Open Payments data?

Ajay Kumar, MD has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.